Effect of progression of disease on cognitive performance in HIV/AIDS

Journal of the National Medical Association

Volumn 98, Issue 8, 2006, Pages 1260-1262

  Odiase, Francis ^a   Ogunrin, Olubunmi ^a,c   Ogunniyi, Adesola ^b  

^a University Teaching Hospital   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c UNIVERSITY OF BENIN   (Nigeria)

Author keywords

CD4 levels; Cognition; HIV AIDS

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COGNITION; COGNITIVE DEFECT; COMMUNITY SCREENING INTERVIEW FOR DEMENTIA; CONTROLLED STUDY; DETERIORATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NIGERIA; PRIORITY JOURNAL; RATING SCALE; SYMPTOMATOLOGY;

ADULT; COGNITION; COGNITION DISORDERS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; NIGERIA; PREVALENCE; PROGNOSIS;

EID: 33746728277     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Berger JR, Moskowitz L, Fischl M, et al. Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome. South Med J. 1987;80:683-686.
2. Casabona J, Sanchez E, Craus F, et al. Trends and survival for AIDS patients presenting with indicative neurologic diseases. Acta Neurol Scand. 1991;84:51-55.
3. Guiloff RJ, Fuller GN, Roberts A, et al. Nature, incidence and prognosis of neurological involvement in the acquired immunodeficiency syndrome in central London. Postgrad. Med J. 1988;64:919-925.
4. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 1985;62:475-495.
5. Snider WD, Simpson DM, Nielsen S, et al. Neurological complications of acquired immunodeficiency syndrome: analysis of 50 patients. Ann Neurol. 1985;14:403-418.
6. Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definition for neurological manifestation of human immunodeficiency virus type 1 (HIV-1) infection. Neurology. 1991;41:778-785.
7. Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol. 1987;44:65-67.
8. De Cock KM, Weiss HA. The global epidemiology of HIV/AIDS. Trop Med Intern Health. 2000;5:A3.
9. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. 2000;12(1):29-37.
10. UNAIDS. Report on the global HIV/AIDS epidemic. Joint United Nations Programme on HIV/AIDS. June 2000.
11. Ogunniyi AO, Hall KS, Gureje O, et al. Cognitive decline and its determinants in a sample of elderly Yoruba. Neuroepidemiology. 2001;20:abstract 1.
12. Hall KS, Ogunniyi AO, Hendrie HC, et al. A cross-cultural community based study of Dementias: methods and performance of the survey instrument- Indianapolis, USA and Ibadan, Nigeria. Int J Methods in Psychiatr Res. 6:125-142.
13. Imarhiagbe F, Ogunrin O, Ogunniyi A. Cognitive performance of hypertensive elderly Nigerians: a case control study. Afr J Med Med Sci. 2005;34:269-273.
14. White DA, Heaton RK, Monsch AU. Neurapsychological studies of asymptomatic human immunodeficiency virus types-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995;1:304-315.
15. Heaton RK, Grant I, Butters N, et al. The HNRC 500-neurapsychology of HIV infection at different stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995;1:231-251.
16. Ferrando SJ. Diagnosis and treatment of HIV-associated neurocognitive disorders. New Dir Ment Health serv. 2000;87:25-35.
17. Smith CA, Van Gorp WG, Ryan ER, et al. Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale. J Acquire Immune Defic Syndr. 2003;33:116-118.
18. Hinkin CH, Castellon SA, Durvasula RS, et al. Medication adherence among HIV-positive adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944-1950.
19. Van Gorp WG, Baerwald JP, Ferrando SJ, et al. The relationship between employment and neuropsychological impairment in HIV infection. J Int Neuropsychol Soc. 1999;5:534-539.
20. Nath A. Human immunodeficiency .virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis. 2002;186(suppl 2):S193-S198.
21. Epstein LG, Gendelman HE. Human immunodeficiency virus type-1 infection of the nervous system: pathogenetic mechanism. Ann Neurol. 1993;33:429-436.
22. Seines OA. Memory loss in persons with HIV/AIDS: assessment and strategies for coping. AIDS Reader. 2005;15:289-294.
23. Clifford DB, Jacoby RG, Miller JP, et al. Neuropsychometric performance of asymptomatic HIV infected subjects. AIDS. 1990;4:767-774.
24. Goethe KE, Mitchell DW. Neuropsychological and neurological functions of human immunodeficiency virus seropositive asymptomatic individuals. Arch Neurol. 1989;46:129-133.
25. Franzblau A, Letz R, Hershman D, et al. Quantitative neurologic and neurobehavioral testing of persons infected with human immunodeficiency virus type 1. Arch Neurol. 1991;48:263-268.
26. McArthur JC, Sacktor N, Seines O. Human immunodeficiency virus-associated dementia. Semin Neurol. 1999;19:129-150.
27. Dore GJ, McDonald A, Li Y, et al. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 2003;17:1539-1545.
28. Hector RK, Velin RA, McCutcher JA, et al. Neuropsychological impairment in human immunodeficiency virus infection: implications for employment. Psychosom Med. 1994;56:8-17.
29. Tross S, Price RW, Navia B, et al. Neuropsychological characterization of the AIDS dementia complex: a preliminary report. AIDS. 1988;2:81-88.
30. Ferrando S, van Gorp W, McElhiney M, et al. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS. 1998;12:F65-F70.
31. Hector RK, Velin RA, Atkinson JH, et al. Neuropsychological impairment in HIV positive male cohorts. In: Stein M, Baum A, eds. Perspectives on Behavioural Medicine. East Sussex, England: Lawrence Erlbaum; 1995:79-93.